A23K10/30

DOG BISCUIT
20230217959 · 2023-07-13 ·

A dog biscuit, such as a morning dog biscuit or an evening dog biscuit, that includes a botanical; a botanical seed or vegetable seed; a digestive enzyme or coenzyme; a probiotic or prebiotic; a vitamin; an animal organ; an egg yolk; a fruit or vegetable; and a bone broth.

DOG BISCUIT
20230217959 · 2023-07-13 ·

A dog biscuit, such as a morning dog biscuit or an evening dog biscuit, that includes a botanical; a botanical seed or vegetable seed; a digestive enzyme or coenzyme; a probiotic or prebiotic; a vitamin; an animal organ; an egg yolk; a fruit or vegetable; and a bone broth.

Late blight resistance gene from <i>Solanum americanum </i>and methods of use

Compositions and methods and for enhancing the resistance of plants to a plant disease caused by a Phytophthora species are provided. The compositions comprise nucleic acid molecules encoding resistance (R) gene products and variants thereof and plants, seeds, and plant cells comprising such nucleic acid molecules. The methods for enhancing the resistance of a plant to a plant disease caused by a Phytophthora species comprise introducing a nucleic acid molecule encoding an R gene product into a plant cell. Additionally provided are methods for using the plants in agriculture to limit plant disease.

Late blight resistance gene from <i>Solanum americanum </i>and methods of use

Compositions and methods and for enhancing the resistance of plants to a plant disease caused by a Phytophthora species are provided. The compositions comprise nucleic acid molecules encoding resistance (R) gene products and variants thereof and plants, seeds, and plant cells comprising such nucleic acid molecules. The methods for enhancing the resistance of a plant to a plant disease caused by a Phytophthora species comprise introducing a nucleic acid molecule encoding an R gene product into a plant cell. Additionally provided are methods for using the plants in agriculture to limit plant disease.

Dried Cheese Pet Chew Treat
20230010968 · 2023-01-12 · ·

A dried chewy cheese product and pet chew treat is described. The cheese chew treat can be shelf-stable, dehydrated, and non-melting. In some embodiments, the cheese chew treat may be formed into a disk shape and may have a central hole. A process for making the dried cheese piece is also described. Methods of making the product may include the steps of pressing and forming the cheese, slicing it to a selected thickness, brining the unfinished cheese pieces, air drying the pieces on a drying rack, dehydrating the product to its final moisture content by placing the unfinished products into a drying chamber at a controlled temperature for a set duration, cooling the product, and removing surface oils.

Pet food feeding system
11547125 · 2023-01-10 · ·

Compositions and methods are disclosed for providing a pet food feeding system or packaged product containing multiple formulations meeting a number of parameters in order to offer diversified ingredients and varied flavors to a pet with minimized digestive stress due to dietary changes.

Pet food feeding system
11547125 · 2023-01-10 · ·

Compositions and methods are disclosed for providing a pet food feeding system or packaged product containing multiple formulations meeting a number of parameters in order to offer diversified ingredients and varied flavors to a pet with minimized digestive stress due to dietary changes.

Nepenthesin-1 derived resistance to fungal pathogens in major crop plants

The invention relates to a genetically modified cereal plant having a recombinant DNA construct comprising a gene encoding a polypeptide having aspartyl protease activity (EC 3.4.23.12) whose expression, particularly in grain, confers enhanced fungal disease resistance as compared to a parent cereal plant from which said genetically modified cereal plant was derived. The invention further relates to a method for producing a genetically modified cereal plant of the invention comprising transforming one or more cells of a parent cereal plant with the recombinant DNA construct; as well as a method for manufacturing the genetically modified grain for production of a crop of genetically modified cereal plants which exhibit increased resistance to a fungal disease due to expression of the recombinant DNA construct. Furthermore, use of grain produced by a genetically modified cereal plant of the invention includes the manufacture of a composition, comprising a milled grain composition, an animal fodder, or steam-pelleted animal fodder.

Nepenthesin-1 derived resistance to fungal pathogens in major crop plants

The invention relates to a genetically modified cereal plant having a recombinant DNA construct comprising a gene encoding a polypeptide having aspartyl protease activity (EC 3.4.23.12) whose expression, particularly in grain, confers enhanced fungal disease resistance as compared to a parent cereal plant from which said genetically modified cereal plant was derived. The invention further relates to a method for producing a genetically modified cereal plant of the invention comprising transforming one or more cells of a parent cereal plant with the recombinant DNA construct; as well as a method for manufacturing the genetically modified grain for production of a crop of genetically modified cereal plants which exhibit increased resistance to a fungal disease due to expression of the recombinant DNA construct. Furthermore, use of grain produced by a genetically modified cereal plant of the invention includes the manufacture of a composition, comprising a milled grain composition, an animal fodder, or steam-pelleted animal fodder.

Complete animal food having cannabinoids in trace concentrations to avoid toxicity

A nutritionally complete animal food including, vitamins, and minerals to sustain the animal's health and wellness. The one or more ingredients containing cannabinoids added to the nutritionally complete animal food at the time of manufacturing. These cannabinoids are selected from the group consisting of Cannabichromenic acid (CBCA), Cannabidiolic acid (CBDA), Cannabidivarinic acid (CBDVA), Cannabigerolic acid (CBGA), Cannabinolic acid (CBNA), Δ9-Tetrahydrocannabinolic acid (THCA), Tetrahydrocannabinolic acid (THCVA) and combinations thereof. The concentrations of each of the cannabinoids are each less than 100 parts per million (ppm) in the at least one ingredient. In an alternate embodiment, the one or more ingredients have cannabinoids include in an aggregate concentration of less than 100 parts per million (ppm).